Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, Concord Biotech has informed that the officials of the Company will be attending an Investor Conference on 26th August 2026 at 01:00 PM to 03:00 PM (IST) organised by Phillip Capital PCG in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
